Toll Free: 1-888-928-9744

Corium International, Inc. (CORI) - Product Pipeline Analysis, 2016 Update

Published: Jun 8, 2016 | Pages: 35 | Publisher: GlobalData | Industry: Medical Devices | Report Format: Electronic (PDF)

Summary

Corium International, Inc. (Corium) is a medical device company that designs, develops and produces therapeutic products. The company products include MicroCor PTH, Tamsulosin TDS and Corplex. Its MicroCor product is a biodegradable microstructure patch technology for active delivery of proteins, peptides and vaccine molecules that require active transport through the skin. The company's Corplex is a novel adhesive system and patch technology for delivery of small molecules. Its manufacturing platform comprises preclinical development through commercial product manufacture, extrusion capabilities and others. The company provides proprietary development programs and contract development and manufacturing services. It has its presence in Grand Rapids and Menlo Park. Corium is headquartered in Menlo Park, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.  

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Corium International, Inc.
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons To Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline 
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
 Table of Contents
Table of Contents 2 List of Tables 4 List of Figures 5 Corium International, Inc. Company Snapshot 6 Corium International, Inc. Company Overview 6 Corium International, Inc. Pipeline Products and Clinical Trials Overview 7 Corium International, Inc.- Pipeline Analysis Overview 9 Key Facts 9 Corium International, Inc. - Major Products and Services 10 Corium International, Inc. Pipeline Products by Development Stage 11 Corium International, Inc. Clinical Trials by Trial Status 13 Corium International, Inc. Pipeline Products Overview 14 Corplex Transdermal System 14 Corplex Transdermal System Product Overview 14 Corplex Transdermal System Clinical Trial 15 Island Dressing 16 Island Dressing Product Overview 16 MicroCor Transdermal System 17 MicroCor Transdermal System Product Overview 17 MicroJet 18 MicroJet Product Overview 18 Rapidly Dissolving Film 19 Rapidly Dissolving Film Product Overview 19 Solid State Film 20 Solid State Film Product Overview 20 Corium International, Inc. - Key Competitors 21 Corium International, Inc. - Key Employees 22 Corium International, Inc. - Locations And Subsidiaries 23 Head Office 23 Other Locations & Subsidiaries 23 Recent Developments 24 Corium International, Inc., Recent Developments 24 May 10, 2016: Corium Reports Second Quarter Fiscal 2016 Financial Results and Recent Corporate Highlights 24 May 02, 2016: Corium Announces Streamlined Bioequivalence Development Path for Transdermal Corplex Donepezil Following Positive Pre-IND Communication from FDA 25 Mar 29, 2016: Corium Announces Positive Preclinical Results with Long-acting Potent GLP-1 Analog Delivered in MicroCor Transdermal Patch 26 Feb 22, 2016: Corium Announces Positive Topline Results From Phase 1 Clinical Study of Transdermal Corplex Memantine as a Potential Treatment of Alzheimer's Disease 27 Feb 08, 2016: Corium Reports First Quarter Fiscal 2016 Financial Results 28 Feb 03, 2016: Corium Announces Positive Topline Results From Phase 1 PK Clinical Study of Once-Weekly Transdermal Corplex Donepezil as a Potential Treatment of Alzheimer's Disease 29 Nov 12, 2015: Corium Reports Fourth Quarter and Fiscal Year 2015 Financial Results and Year-End Highlights 30 Aug 26, 2015: Corium Announces Issuance of U.S. Patent for MicroCor Transdermal System for a Broad Range of Therapeutics and Vaccines 31 Aug 25, 2015: Corium Initiates Phase 1 Clinical Trial of Corplex Donepezil Transdermal System for the Treatment of Alzheimer's Disease 32 Jul 29, 2015: Corium Reports Third Quarter Fiscal 2015 Financial Results 32 Appendix 35 Methodology 35 About GlobalData 35 Contact Us 35 Disclaimer 35
List of Tables
Corium International, Inc. Pipeline Products and Clinical Trials Overview 7 Corium International, Inc. Pipeline Products by Equipment Type 7 Corium International, Inc. Pipeline Products by Indication 8 Corium International, Inc. Clinical Trials by Trial Status 8 Corium International, Inc., Key Facts 9 Corium International, Inc., Major Products and Services 10 Corium International, Inc. Number of Pipeline Products by Development Stage 11 Corium International, Inc. Pipeline Products Summary by Development Stage 12 Corium International, Inc. Clinical Trials by Trial Status 13 Corium International, Inc. Clinical Trials Summary 13 Corplex Transdermal System - Product Status 14 Corplex Transdermal System - Product Description 14 Corplex Transdermal System - Phase 1 Clinical Trial of Corplex Donepezil Transdermal System for the Treatment of Alzheimer's Disease 15 Island Dressing - Product Status 16 Island Dressing - Product Description 16 MicroCor Transdermal System - Product Status 17 MicroCor Transdermal System - Product Description 17 MicroJet - Product Status 18 MicroJet - Product Description 18 Rapidly Dissolving Film - Product Status 19 Rapidly Dissolving Film - Product Description 19 Solid State Film - Product Status 20 Solid State Film - Product Description 20 Corium International, Inc., Key Employees 22 Corium International, Inc., Other Locations 23


List of Figures
Corium International, Inc. Pipeline Products by Equipment Type 8 Corium International, Inc. Pipeline Products by Development Stage 11 Corium International, Inc. Clinical Trials by Trial Status 13

To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global amino acids market size is anticipated to be valued at USD 35.4 billion by 2022, as per a new research report by Radiant Insights, Inc. Increase in animal feed additive demand owing to regulate metabolism in livestock production owing to growi

Read More...

Global outsourced customer care services market is projected to reach USD 84.7 billion by 2020, as per a new research report by Radiant Insights, Inc. Swelling need for interaction through non-voice channels is estimated to boost global demand over t

Read More...

Global activated carbon market size is likely to be valued at USD 5.3 billion by 2020; as per a new research report by Radiant Insights, Inc. Increase in commercial & residential waste water treatment demand owing to escalation in water prices is ant

Read More...

Global Biocides market size is likely to be valued at USD 11.9 billion by 2022; as per a new research report by Radiant Insights, Inc. Growth in water treatment process units particularly in China, Japan and India is likely to drive demand. Increasin

Read More...

Global polymethyl methacrylate (PMMA) market size is likely to be valued at USD 11.65 billion by 2022; as per a new research report by Radiant Insights, Inc. Increasing spending on advertising & marketing for building strong brand equity and product

Read More...
Choose License Type
Single User - US $750
Multi User - US $1500
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify